These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20511674)

  • 1. Rapamycin reduces intrahepatic alpha-1-antitrypsin mutant Z protein polymers and liver injury in a mouse model.
    Kaushal S; Annamali M; Blomenkamp K; Rudnick D; Halloran D; Brunt EM; Teckman JH
    Exp Biol Med (Maywood); 2010 Jun; 235(6):700-9. PubMed ID: 20511674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
    Tang Y; Fickert P; Trauner M; Marcus N; Blomenkamp K; Teckman J
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G156-65. PubMed ID: 27102560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1-antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model.
    Lindblad D; Blomenkamp K; Teckman J
    Hepatology; 2007 Oct; 46(4):1228-35. PubMed ID: 17886264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of Alpha-1 Antitrypsin Deficiency Liver Disease.
    Teckman JH; Blomenkamp KS
    Methods Mol Biol; 2017; 1639():1-8. PubMed ID: 28752441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBG1 Is the Final Arbitrator of A1AT-Z Degradation.
    Wen JH; Wen H; Gibson-Corley KN; Glenn KA
    PLoS One; 2015; 10(8):e0135591. PubMed ID: 26295339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.
    Brunt EM; Blomenkamp K; Ahmed M; Ali F; Marcus N; Teckman J
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):626-30. PubMed ID: 20890217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.
    Rudnick DA; Shikapwashya O; Blomenkamp K; Teckman JH
    Hepatology; 2006 Oct; 44(4):976-82. PubMed ID: 17006946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.
    Hidvegi T; Ewing M; Hale P; Dippold C; Beckett C; Kemp C; Maurice N; Mukherjee A; Goldbach C; Watkins S; Michalopoulos G; Perlmutter DH
    Science; 2010 Jul; 329(5988):229-32. PubMed ID: 20522742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic heteropolymerization of M and Z alpha-1-antitrypsin.
    Laffranchi M; Elliston EL; Miranda E; Perez J; Ronzoni R; Jagger AM; Heyer-Chauhan N; Brantly ML; Fra A; Lomas DA; Irving JA
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32699193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitation of Monomer and Polymer Alpha-1 Antitrypsin by Centrifugal Separation and Assay by Western Blot of Soluble and Insoluble Components.
    Blomenkamp KS; Teckman JH
    Methods Mol Biol; 2017; 1639():227-234. PubMed ID: 28752463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.
    Greene CM; Miller SD; Carroll T; McLean C; O'Mahony M; Lawless MW; O'Neill SJ; Taggart CC; McElvaney NG
    J Inherit Metab Dis; 2008 Feb; 31(1):21-34. PubMed ID: 18193338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.
    Tang Y; Blomenkamp KS; Fickert P; Trauner M; Teckman JH
    PLoS One; 2018; 13(8):e0200897. PubMed ID: 30067827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative isolation of alphalAT mutant Z protein polymers from human and mouse livers and the effect of heat.
    An JK; Blomenkamp K; Lindblad D; Teckman JH
    Hepatology; 2005 Jan; 41(1):160-7. PubMed ID: 15619240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency.
    Teckman JH; An JK; Blomenkamp K; Schmidt B; Perlmutter D
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G851-62. PubMed ID: 14684378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in alpha-1-antitrypsin deficiency liver disease.
    Teckman JH; Jain A
    Curr Gastroenterol Rep; 2014 Jan; 16(1):367. PubMed ID: 24338605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency.
    Lawless MW; Greene CM; Mulgrew A; Taggart CC; O'Neill SJ; McElvaney NG
    J Immunol; 2004 May; 172(9):5722-6. PubMed ID: 15100318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting intracellular degradation pathways for treatment of liver disease caused by α1-antitrypsin deficiency.
    Wang Y; Perlmutter DH
    Pediatr Res; 2014 Jan; 75(1-2):133-9. PubMed ID: 24226634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-1-antitrypsin deficiency: current concepts.
    Mulgrew AT; Taggart CC; McElvaney NG
    Lung; 2007; 185(4):191-201. PubMed ID: 17562108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
    Rudnick DA; Liao Y; An JK; Muglia LJ; Perlmutter DH; Teckman JH
    Hepatology; 2004 Apr; 39(4):1048-55. PubMed ID: 15057909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulator of G Signaling 16 is a marker for the distinct endoplasmic reticulum stress state associated with aggregated mutant alpha1-antitrypsin Z in the classical form of alpha1-antitrypsin deficiency.
    Hidvegi T; Mirnics K; Hale P; Ewing M; Beckett C; Perlmutter DH
    J Biol Chem; 2007 Sep; 282(38):27769-80. PubMed ID: 17635928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.